McNamara Peter (CIK 2023255) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy TECX (43 shares), Sell TECX (43 shares), Buy TECX (172 shares), Sell TECX (172 shares), Buy TECX (2,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 43 | $633 |
| 2026-08-14 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 43 | $1,505 |
| 2026-07-01 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 172 | $2,530 |
| 2026-07-01 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 172 | $6,020 |
| 2026-03-09 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 2,500 | $5,950 |
| 2026-03-09 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 215 | $3,163 |
| 2026-03-09 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 6,047 | $181,410 |
| 2026-03-09 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 215 | $7,525 |
| 2026-03-05 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 1,649 | $36,377 |
| 2026-03-05 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 23,000 | $0 |
| 2026-03-05 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 1,650 | $41,250 |
| 2026-02-10 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Sell | 1,748 | $40,589 |
| 2025-12-29 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 7,000 | $20,860 |
| 2025-09-29 | Tectonic Therapeutic, Inc. (TECX) | Chief Scientific Officer | Buy | 4,550 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14